Screener
Phathom Pharmaceuticals, Inc. PHAT Q2 2025 earnings
Reported August 7, 2025 · Before market open
Revenue$39.5MMiss by $7.3M
EPS-$0.79Miss by $0.03
Revenue estimate$46.8M
EPS estimate-$0.76
Next report
Date not yet announcedValuation & ratios
Segments
Versus estimates
Revenue
Diluted EPS
FAQ
- When did Phathom Pharmaceuticals, Inc. report Q2 2025 earnings?
- Phathom Pharmaceuticals, Inc. (PHAT) reported Q2 2025 earnings on August 7, 2025 before market open.
- What were Phathom Pharmaceuticals, Inc.'s Q2 2025 revenue and EPS?
- Phathom Pharmaceuticals, Inc. reported revenue of $39.5M and eps of $-0.79 for Q2 2025.
- Did Phathom Pharmaceuticals, Inc. beat estimates in Q2 2025?
- Revenue missed the consensus estimate of $46.8M by $7.3M. EPS missed the consensus estimate of $-0.76 by $0.03.
- How did Phathom Pharmaceuticals, Inc.'s Q2 2025 results compare year-over-year?
- Compared to the same quarter a year prior, revenue grew 439.4% from $7.3M a year earlier and eps grew 36.8% from $-1.25.
- Where can I find Phathom Pharmaceuticals, Inc.'s Q2 2025 SEC filings?
- You can read the 8-K earnings release (0001193125-25-174943) and the 10-Q periodic report (0000950170-25-104548) directly on SEC EDGAR. The filing index links above go to sec.gov.
